56 Results for "

TEAD1

" in MedChemExpress (MCE) Product Catalog:
Products (56)

56 Results for "TEAD1" in MCE Product Catalog:

  • Isoforms Recommended:
5
5 Cited Publications
Cat. No.: HY-134955
CAS No.: 2290608-13-6
Purity:  99.64%
Target:  

YAP

Research Areas:  

Cancer

VT103, an analog of VT101, is an orally active and selective TEAD1 protein palmitoylation inhibitor. VT103 inhibits YAP/TAZ-TEAD promoted gene transcription, blocks TEAD auto-palmitoylation, and disrupts interaction between YAP/TAZ and TEAD. VT103 can be used for the research of cancer [1].
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-134956
CAS No.: 2417718-25-1
Purity:  99.94%
Target:  

YAP

Research Areas:  

Cancer

VT104 is a potent and orally active YAP/TAZ inhibitor. VT104 prevents palmitoylation of endogenous TEAD1 and TEAD3 proteins. VT104 can be used in research of cancer [1] .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-147135
CAS No.: 2416418-11-4
Purity:  98.48%
Synonyms: TEAD-IN-3
Target:  

YAP Apoptosis

Research Areas:  

Cancer

MYF-03-69 (TEAD-IN-3) is a covalent and irreversible TEAD inhibitor with IC50s of 385, 143, 558 and 173 nM for TEAD1, TEAD2, TEAD3 and TEAD4. MYF-03-69 disrupts YAP-TEAD association, suppresses TEAD transcriptional activity (IC50 = 56 nM) and up-regulates apoptosis gene BMF. MYF-03-69 selectively inhibits mesothelioma cancer cells with defective Hippo signaling. MYF-03-69 can be used for the study of malignant pleural mesothelioma (MPM) [1].
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P2244
CAS No.: 1659305-78-8
Target:  

YAP

Research Areas:  

Cancer

YAP-TEAD-IN-1 is a potent and competitive inhibitor of?YAP–TEAD interaction (IC50=25 nM). YAP-TEAD-IN-1 is a 17mer peptide and shows a higher the binding affinity to TEAD1 (Kd=15 nM) than YAP (50-171) (Kd=40 nM) [1].
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P2244A
CAS No.: 1659305-79-9
Target:  

YAP

Research Areas:  

Cancer

YAP-TEAD-IN-1 TFA is a potent and competitive peptide inhibitor of YAP-TEAD interaction (IC50=25 nM). YAP-TEAD-IN-1 TFA is a 17mer peptide and shows a higher the binding affinity to TEAD1 (Kd=15 nM) than YAP (50-171) (Kd= 40 nM) [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-147136
CAS No.: 2857937-59-6
Purity:  99.52%
Target:  

YAP

Research Areas:  

Cancer

MYF-03-176 is an orally active inhibitor of TEAD, and suppresses TEAD transcriptional activity with an IC50 of 11 nM. The IC50 values of MYF-03-176 for TEAD1, TEAD3, and TEAD4 are 47, 32, and 71 nM, respectively. MYF-03-176 inhibits hippo signaling defective malignant pleural mesothelioma (MPM) cells. MYF-03-176 shows strong antitumor efficacy in MPM mouse xenograft model [1] .
loading...
    loading...
Cat. No.: HY-172113
Target:  

PROTACs YAP c-Myc Apoptosis

Research Areas:  

Cancer

H122 is a PROTAC degrader for TEAD that degrades TEAD1 with a DC50 of 3 nM. H122 exhibits good affinity to TEAD2, TEAD3, and TEAD4 with Ki values of 2.0, 3.6 and 1.6 nM, respectively. H122 relies on binding to TEAD1 and CRBN, functional E3 ligase activity, and a functional proteasome for degradation.H122 induces degradation of TEAD3 and forms a ternary complex with TEAD4 and CRBN/DDB1 to mediate degradation.H122 downregulates expression of Myc target genes. H122 exhibits antitumor efficacy in MSTO-211H mouse xenograft models.H122 can be used for the research of malignant mesothelioma [1].
loading...
    loading...
Cat. No.: HY-174275
CAS No.: 2762619-63-4
Target:  

YAP

Research Areas:  

Inflammation/Immunology Cancer

TEAD1/3/4-IN-1 is an orally active inhibitor of TEAD1/3/4. TEAD1/3/4-IN-1 inhibits the YAP/TAZ-TEAD interaction, with its EC50 being 2 nM. TEAD1/3/4-IN-1 has anti-proliferative activity against NCI-H226 cells. TEAD1/3/4-IN-1 can be used in the research of lung squamous cell carcinoma [1].
loading...
    loading...
Cat. No.: HY-147208
CAS No.: 2738542-58-8
Purity:  99.87%
Target:  

YAP

Research Areas:  

Cancer

MSC-4106 is an orally active and potent inhibitor of YAP/TAZ-TEAD. MSC-4106 inhibits TEAD1 or TEAD3 auto-palmitoylation and shows inhibitory effect on NCI-H226 tumor xenograft model [1].
loading...
    loading...
Cat. No.: HY-161569
CAS No.: 3032196-88-3
Target:  

YAP

Research Areas:  

Cancer

TEAD-IN-11 (compound 38) has a good inhibitory effect on TEAD1 (IC50=8.7 nM), TEAD2 (IC50=3.4 nM), TEAD3 (IC50=5.6 nnM). TEAD-IN-11 has good selective activity against TEAD1-3 as a covalent inhibitor. TEAD-IN-11 can be used for cancer research [1].
loading...
    loading...
Cat. No.: HY-147088
CAS No.: 2563849-97-6
Purity:  98.14%
Target:  

YAP

Research Areas:  

Cancer

TEAD-IN-2 is a novel, orally active inhibitor of transcriptional enhancer associate domain (TEAD) and modulates TEAD by ubiquitination and/or degradation by compounds. TEAD-IN-2 can be used for the research of a variety of diseases, disorders or conditions associated with TEAD .
loading...
    loading...
Cat. No.: HY-RS14342
Research Areas:  

Others

TEAD1 Human Pre-designed siRNA Set A contains three designed siRNAs for TEAD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS17084
Research Areas:  

Others

Tead1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Tead1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-161443
Target:  

YAP

Research Areas:  

Cancer

TEAD-IN-9 (compound 17) is a TEAD1 inhibitor with an IC50 of 0.29 μM. TEAD-IN-9 targets the palmitoyl pocket of TEAD, thereby effectively inhibiting the binding of YAP-TEAD and blocking the transcriptional function of YAP-TEAD .
loading...
    loading...
Cat. No.: HY-RS23528
Research Areas:  

Others

Tead1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Tead1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-170764
CAS No.: 2738550-24-6
Target:  

YAP

Research Areas:  

Cancer

M3686 (Compound 29) is a potent, selective TEAD1 inhibitor with an IC50 value of 51 nM. M3686 also shows weaker binding activity on TEAD3. M3686 potently inhibits cell viability against YAP-dependent NCI-H226 cell line with an IC50 value of 0.06 uM. M3686 shows strong anti-tumor effects in the NCI-H226 xenograft model [1].
loading...
    loading...
Cat. No.: HY-161568
CAS No.: 3032196-65-6
Target:  

YAP

Research Areas:  

Cancer

TEAD-IN-10 (compound 15) has good selective activity and inhibitory effect on TEAD1 (IC50=14 nM), TEAD2 (IC50=179 nM) and TEAD3 (IC50=4 nnM) as a covalent inhibitor. TEAD-IN-10 can be used for cancer research [1].
loading...
    loading...
Cat. No.: HY-168506
Target:  

YAP

Research Areas:  

Cancer

MSC-1254 is a reversible, selective and covalent TEAD1 inhibitor. MSC-1254 can be used for the study of cancer [1].
loading...
    loading...
Cat. No.: HY-181534
Target:  

PROTACs YAP IAP SNIPERs

Research Areas:  

Cancer

PROTAC TEAD1/IAP degrader-1 (Compound A232) is a selective TEAD1 and cIAP1 PROTAC degrader, with DC50 values of 14 nM and 270 nM, respectively. PROTAC TEAD1/IAP degrader-1 promotes the ubiquitination and degradation of TEAD1 and cIAP1. PROTAC TEAD1/IAP degrader-1 downregulates the expression of the TEAD-dependent gene CTGF. PROTAC TEAD1/IAP degrader-1 exhibits anticancer activity against mesothelioma [1].
loading...
    loading...
Cat. No.: HY-181537
Target:  

PROTACs SNIPERs YAP IAP

Research Areas:  

Cancer

PROTAC TEAD1/IAP degrader-2 is an IAP-harnessing TEAD1 PROTAC degrader, with a DC50 of 170 nM against TEAD1 in NCI-H2052 cells. PROTAC TEAD1/IAP degrader-2 exhibits moderate antiproliferative activity in Hippo pathway-dependent mesothelioma cells. PROTAC TEAD1/IAP degrader-2 inhibits the expression of CTGF, but with a weaker effect than the TEAD inhibitor VT-107 (HY-134957). PROTAC TEAD1/IAP degrader-2 can be used in mesothelioma-related research [1].
loading...
    loading...